Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease
Nikolaus Feucht, Etienne Michael Schönbach, Ines Lanzl, Konstantin Kotliar, Chris Patrick Lohmann, Mathias MaierDepartment of Ophthalmology, Technical University of Munich, Munich, GermanyPurpose: To investigate changes in the area of the foveal avascular zone (FAZ) in patients with ret...
Main Authors: | Feucht N, Schönbach EM, Lanzl I, Kotliar K, Lohmann CP, Maier M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-01-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/changes-in-the-foveal-microstructure-after-intravitreal-bevacizumab-ap-a12008 |
Similar Items
-
Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion
by: Mei-Zi Wang, et al.
Published: (2016-01-01) -
Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
by: Dan Călugăru, et al.
Published: (2017-09-01) -
Intravitreal bevacizumab for pediatric exudative retinal diseases
by: Abdelrahman G. Salman, MD, FRCS
Published: (2011-04-01) -
Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients
by: Isola V, et al.
Published: (2013-03-01) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
by: Juan Carlos Mesa Gutiérrez, et al.
Published: (2008-09-01)